Roche

| May 27, 2016

NEW DELHI: Biotech giant Roche has taken the National Pharmaceutical Pricing Authority (NPPA) - India's drug pricing watchdog to court over the ceiling price it fixed for breast cancer injection trastuzumab......

| May 25, 2016

NEW DELHI: The Delhi High Court has once again asked Swiss biotech drug giant Roche to explain why it is suing the Drug Controller General of India (DCGI) and Hyderabad-based Hetero Drugs over the approval process for a biosimilar or copy of complex biotech cancer drug bevacizumab. Roche, which invented the drug and markets it under the blockbuster brand 'Avastin', has argued that Hetero's drug is not a biosimilar to bevacizumab and therefore can't use the name to market itself here......

Montefiore Health System | June 15, 2016

Montefiore New Rochelle and Montefiore Mount Vernon have both earned the Westchester Green Business Certification, the region’s only green business certification program for local organizations that are leaders in incorporating sustainability into all aspects of business. A trailblazer in producing and using sustainable energy since 1993, Montefiore is being honored for ecofriendly initiatives that have resulted in a “greener” Westchester and for its commitment to a 30 percent ...

EHRIntelligence | January 16, 2020

Eighty-four percent of EHR users are dissatisfied with the technical service and basic software account support from current EHR and HIT vendors, according to a 2020 Black Book Research survey. Since the HITECH Act was signed into law in 2009, EHRs have not only been more prevalent, but they have continued to change and evolve. However, technical service from EHR vendors hasn’t kept up with the constant change, according to high-level hospital tech managers. Healthcare software support is ...